Perceptive Advisors LLC Bio Xcel Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
A detailed history of Perceptive Advisors LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 439,500 shares of BTAI stock, worth $615,300. This represents 0.09% of its overall portfolio holdings.
Number of Shares
439,500Holding current value
$615,300% of portfolio
0.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BTAI
# of Institutions
3Shares Held
445KCall Options Held
0Put Options Held
0About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $39.2M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...